Deutsche Bank’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
+6,066
| New | +$137K | ﹤0.01% | 3125 |
|
|
2021
Q3 | – | Sell |
-291
| Closed | -$89K | – | 4528 |
|
|
2021
Q2 | $89K | Sell |
291
-904
| -76% | -$276K | ﹤0.01% | 4079 |
|
|
2021
Q1 | $246K | Sell |
1,195
-125
| -9% | -$25.7K | ﹤0.01% | 3496 |
|
|
2020
Q4 | $264K | Buy |
1,320
+26
| +2% | +$5.2K | ﹤0.01% | 3272 |
|
|
2020
Q3 | $214K | Buy |
1,294
+445
| +52% | +$73.6K | ﹤0.01% | 3143 |
|
|
2020
Q2 | $211K | Buy |
849
+105
| +14% | +$26.1K | ﹤0.01% | 3079 |
|
|
2020
Q1 | $135K | Sell |
744
-790
| -51% | -$143K | ﹤0.01% | 3089 |
|
|
2019
Q4 | $443K | Buy |
1,534
+1,338
| +683% | +$386K | ﹤0.01% | 2763 |
|
|
2019
Q3 | $52K | Sell |
196
-272
| -58% | -$72.2K | ﹤0.01% | 3803 |
|
|
2019
Q2 | $175K | Sell |
468
-495
| -51% | -$185K | ﹤0.01% | 3815 |
|
|
2019
Q1 | $257K | Sell |
963
-1,415
| -60% | -$378K | ﹤0.01% | 3785 |
|
|
2018
Q4 | $505K | Buy |
2,378
+530
| +29% | +$113K | ﹤0.01% | 3277 |
|
|
2018
Q3 | $828K | Buy |
1,848
+469
| +34% | +$210K | ﹤0.01% | 3434 |
|
|
2018
Q2 | $559K | Sell |
1,379
-1,025
| -43% | -$416K | ﹤0.01% | 3730 |
|
|
2018
Q1 | $1.31M | Buy |
2,404
+234
| +11% | +$128K | ﹤0.01% | 3122 |
|
|
2017
Q4 | $1.31M | Buy |
2,170
+1,386
| +177% | +$837K | ﹤0.01% | 2978 |
|
|
2017
Q3 | $359K | Buy |
784
+291
| +59% | +$133K | ﹤0.01% | 3488 |
|
|
2017
Q2 | $198K | Sell |
493
-324
| -40% | -$130K | ﹤0.01% | 3779 |
|
|
2017
Q1 | $169K | Buy |
+817
| New | +$169K | ﹤0.01% | 3524 |
|
|
2016
Q4 | – | Sell |
-433
| Closed | -$63K | – | 4541 |
|
|
2016
Q3 | $63K | Buy |
+433
| New | +$63K | ﹤0.01% | 3881 |
|